The project coordinator Latvian Biomedical Research and Study Centre (LBMC) is an independent state funded research institute which is involved in both fundamental and applied research. Being the largest institute in the biomedicine research field and acting as a hub between major Universities and hospitals, LBMC covers all main research areas including Human genetics, Cancer research, Recombinant biotechnology, Structural biology, Molecular virology, Infectious diseases, and Molecular pharmacology. The most recent evaluation of research performance by Technopolis group confirmed LBMC as a centre of scientific excellence in Latvia.
University of Dundee (UNIVDUN) is one of the UK’s leading universities and one of the strongest research hubs in Europe, internationally recognized for its expertise across a range of disciplines including Life Sciences, Medicine, and Engineering. UNIVDUN is committed to translating their research outputs into innovative solutions for health, the environment and the economy. It has developed strong links with the commercial sector and is committed to engaging with the public to increase awareness of the significance of research to society.
The Weizmann Institute of Science (WEIZMANN), located in Rehovot, Israel is one of the top-ranking multidisciplinary research institutions in the world. Noted for its wide-ranging exploration of the sciences and technology, the Institute gathers together over 240 research laboratories focused on biological sciences, chemistry, physics, mathematics and computer sciences, with over 2,500 scientists, technicians and research students. Weizmann is widely recognized as an international leader in the area of systems and computational biology.
Lund University (ULUND) is one of the largest and oldest universities in Scandinavia. Participants from ULUND are all members of the Lund University Diabetes Centre (LUDC), a Centre of Excellence funded in 2006 by the Swedish Research Council and one of the leading diabetes research centres in the world. PIs are located at the Clinical Research Centre of the University, in close connection to the Scania University Hospital, facilitating extensive interaction and collaboration with clinicians and creating the ideal setting for basic, clinical and translational research. The Centre, with >200 researchers and some of the best-characterised clinical studies in diabetes, covers all aspects of diabetes research, with special emphasis on diabetes genetics and epigenetics.